193 related articles for article (PubMed ID: 26058995)
1. Incidence of cervical dysplasia and cervical cancer in women living with HIV in Denmark: comparison with the general population.
Thorsteinsson K; Ladelund S; Jensen-Fangel S; Katzenstein TL; Johansen IS; Pedersen G; Junge J; Helleberg M; Storgaard M; Obel N; Lebech AM
HIV Med; 2016 Jan; 17(1):7-17. PubMed ID: 26058995
[TBL] [Abstract][Full Text] [Related]
2. Incidence of cervical dysplasia and cervical cancer in women living with HIV in Denmark: comparison with the general population.
Thorsteinsson K; Ladelund S; Jensen-Fangel S; Katzenstein TL; Johansen IS; Pedersen G; Junge J; Helleberg M; Storgaard M; Obel N; Lebech AM
J Int AIDS Soc; 2014; 17(4 Suppl 3):19646. PubMed ID: 25394150
[TBL] [Abstract][Full Text] [Related]
3. Adherence to the cervical cancer screening program in women living with HIV in Denmark: comparison with the general population.
Thorsteinsson K; Ladelund S; Jensen-Fangel S; Katzenstein TL; Johansen IS; Pedersen G; Junge J; Helleberg M; Storgaard M; Lebech AM
BMC Infect Dis; 2014 May; 14():256. PubMed ID: 24885577
[TBL] [Abstract][Full Text] [Related]
4. Impact of immunosuppression and region of birth on risk of cervical intraepithelial neoplasia among migrants living with HIV in Sweden.
Carlander C; Wagner P; Svedhem V; Elfgren K; Westling K; Sönnerborg A; Sparén P
Int J Cancer; 2016 Oct; 139(7):1471-9. PubMed ID: 27177207
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and distribution of cervical high-risk human papillomavirus and cytological abnormalities in women living with HIV in Denmark - the SHADE.
Thorsteinsson K; Storgaard M; Katzenstein TL; Ladelund S; Rønsholt FF; Johansen IS; Pedersen G; Hashemi L; Nielsen LN; Nilas L; Obel N; Bonde J; Lebech AM
BMC Cancer; 2016 Nov; 16(1):866. PubMed ID: 27821088
[TBL] [Abstract][Full Text] [Related]
6. Persistence of cervical high-risk human papillomavirus in women living with HIV in Denmark - the SHADE.
Thorsteinsson K; Ladelund S; Storgaard M; Katzenstein TL; Johansen IS; Pedersen G; Rönsholt FF; Nielsen LN; Nilas L; Franzmann M; Obel N; Lebech AM; Bonde J
BMC Infect Dis; 2019 Aug; 19(1):740. PubMed ID: 31438877
[TBL] [Abstract][Full Text] [Related]
7. Multiple High-Risk HPV Types Contribute to Cervical Dysplasia in Ugandan Women Living With HIV on Antiretroviral Therapy.
Nakisige C; Adams SV; Namirembe C; Okoche L; Ferrenberg J; Towlerton A; Larsen A; Orem J; Casper C; Frenkel L; Uldrick TS
J Acquir Immune Defic Syndr; 2022 Jul; 90(3):333-342. PubMed ID: 35195571
[TBL] [Abstract][Full Text] [Related]
8. The burden of cervical pre-cancer and cancer in HIV positive women in Zambia: a modeling study.
Bateman AC; Katundu K; Mwanahamuntu MH; Kapambwe S; Sahasrabuddhe VV; Hicks ML; Chi BH; Stringer JS; Parham GP; Chibwesha CJ
BMC Cancer; 2015 Jul; 15():541. PubMed ID: 26205980
[TBL] [Abstract][Full Text] [Related]
9. CIN 2/3 and cervical cancer in an organised screening programme after an unsatisfactory or a normal Pap smear: a seven-year prospective study of the Norwegian population-based screening programme.
Nygård JF; Sauer T; Nygård M; Skare GB; Thoresen SØ
J Med Screen; 2004; 11(2):70-6. PubMed ID: 15153321
[TBL] [Abstract][Full Text] [Related]
10. Incidence of cervical precancers among HIV-seropositive women.
Massad LS; Xie X; D'Souza G; Darragh TM; Minkoff H; Wright R; Colie C; Sanchez-Keeland L; Strickler HD
Am J Obstet Gynecol; 2015 May; 212(5):606.e1-8. PubMed ID: 25499260
[TBL] [Abstract][Full Text] [Related]
11. Suppressive antiretroviral therapy associates with effective treatment of high-grade cervical intraepithelial neoplasia.
Carlander C; Wagner P; van Beirs A; Yilmaz A; Elfgren K; Dillner J; Sönnerborg A; Sparén P
AIDS; 2018 Jul; 32(11):1475-1484. PubMed ID: 29746299
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of thermal ablation for treatment of biopsy-confirmed high-grade cervical precancer among women living with HIV in Kenya.
Mungo C; Osongo CO; Ambaka J; Omoto J; Cohen CR
Int J Cancer; 2023 Dec; 153(12):1971-1977. PubMed ID: 37715464
[TBL] [Abstract][Full Text] [Related]
13. Long-term risk of cervical cancer following conization of cervical intraepithelial neoplasia grade 3-A Danish nationwide cohort study.
Sand FL; Frederiksen K; Munk C; Jensen SM; Kjaer SK
Int J Cancer; 2018 May; 142(9):1759-1766. PubMed ID: 29218720
[TBL] [Abstract][Full Text] [Related]
14. Immunodeficiency and the risk of cervical intraepithelial neoplasia 2/3 and cervical cancer: A nested case-control study in the Swiss HIV cohort study.
Clifford GM; Franceschi S; Keiser O; Schöni-Affolter F; Lise M; Dehler S; Levi F; Mousavi M; Bouchardy C; Wolfensberger A; Darling KE; Staehelin C; Bertisch B; Kuenzli E; Bernasconi E; Pawlita M; Egger M;
Int J Cancer; 2016 Apr; 138(7):1732-40. PubMed ID: 26537763
[TBL] [Abstract][Full Text] [Related]
15. Cervical intraepithelial neoplasia and invasive cancer risks in women infected with HIV in the French West Indies.
Kadhel P; Multigner L; Bardinet F; Goerger-Sow M; Janky E
HIV Med; 2012 Jan; 13(1):79-82. PubMed ID: 21819528
[TBL] [Abstract][Full Text] [Related]
16. Human Immunodeficiency Virus (HIV)- and Non-HIV-Associated Immunosuppression and Risk of Cervical Neoplasia.
Silverberg MJ; Leyden WA; Chi A; Gregorich S; Huchko MJ; Kulasingam S; Kuppermann M; Seto A; Smith-McCune KK; Sawaya GF
Obstet Gynecol; 2018 Jan; 131(1):47-55. PubMed ID: 29215531
[TBL] [Abstract][Full Text] [Related]
17. HIV infection as a risk factor for cervical cancer and cervical intraepithelial neoplasia in Senegal.
Holmes RS; Hawes SE; Touré P; Dem A; Feng Q; Weiss NS; Kiviat NB
Cancer Epidemiol Biomarkers Prev; 2009 Sep; 18(9):2442-6. PubMed ID: 19690181
[TBL] [Abstract][Full Text] [Related]
18. Risk of vaginal cancer among hysterectomised women with cervical intraepithelial neoplasia: a population-based national cohort study.
Alfonzo E; Holmberg E; Sparén P; Milsom I; Strander B
BJOG; 2020 Mar; 127(4):448-454. PubMed ID: 31769577
[TBL] [Abstract][Full Text] [Related]
19. Cervical precancer and cancer incidence among insured women with and without HIV in South Africa.
Fernández Villalobos NV; Ruffieux Y; Haas AD; Chinogurei C; Cornell M; Taghavi K; Egger M; Folb N; Maartens G; Rohner E
Int J Cancer; 2024 Jan; 154(2):273-283. PubMed ID: 37658695
[TBL] [Abstract][Full Text] [Related]
20. Support for lowering cervical cancer screening age to 25 for women living with HIV: retrospective cross-sectional programmatic data from Botswana.
Ramogola-Masire D; Grover S; Mathoma A; Monare B; Gabaitiri L; Bazzett-Matabele L; Hofmeyr G; Morroni C; Luckett R
BMC Womens Health; 2022 Apr; 22(1):100. PubMed ID: 35366863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
